Presentation is loading. Please wait.

Presentation is loading. Please wait.

IL-6-dependent changes in preclinical phase of arthritis in gp130F759.

Published byἉλκυόνη Βιλαέτης Modified over 5 years ago

Similar presentations

Presentation on theme: "IL-6-dependent changes in preclinical phase of arthritis in gp130F759."— Presentation transcript:

1 IL-6-dependent changes in preclinical phase of arthritis in gp130F759.
IL-6-dependent changes in preclinical phase of arthritis in gp130F759. Multiple parameters of WT, Il6KO (abbreviated as KO), gp130F759 (F759) and Il6KO/gp130F759 (KO/F759) at 5–6 months old (n=4 each) were examined. As systemic changes, (A) weight of the spleen, (B) serum titres of CRP, RF-IgM, and anti-CCP IgM are indicated at top. As a local changes in the joints, (C) Il6 gene expression by real time PCR, (D) the relative amounts of PAD4 protein by western blot {the average ratio of band densities (PAD4/β-actin) of WT=1.0} and (E) synovial cell numbers are indicated at bottom. Statistical significance was estimated by the Kruskal-Wallis test and Dunn’s method. ND; not detectable. CCP, circular citrullinated peptide; CRP, C reactive protein. Ayano Yahagi et al. RMD Open 2019;5:e000853 Copyright © BMJ Publishing Group & EULAR. All rights reserved.

Download ppt "IL-6-dependent changes in preclinical phase of arthritis in gp130F759."

Similar presentations

The genomic region spanning rs shows enhancer activity.

The genomic region spanning rs shows enhancer activity.
Multivariable model of abatacept retention in biologic-naïve patients.

Multivariable model of abatacept retention in biologic-naïve patients.
Receiver operating characteristic (ROC) curves: rapid radiographic progression prognosis by anticyclic citrullinated peptides generation 2 antibodies (anti-CCP2),

Receiver operating characteristic (ROC) curves: rapid radiographic progression prognosis by anticyclic citrullinated peptides generation 2 antibodies (anti-CCP2),
Multivariable model of abatacept retention by RF and anti-CCP status in biologic-naïve patients with or without radiographic erosion at baseline. Multivariable.

Multivariable model of abatacept retention by RF and anti-CCP status in biologic-naïve patients with or without radiographic erosion at baseline. Multivariable.
(A) EULAR response based on DAS28 (ESR, otherwise CRP) and (B) Boolean remission, at 6 months in patients treated with abatacept as a first-line biologic.

(A) EULAR response based on DAS28 (ESR, otherwise CRP) and (B) Boolean remission, at 6 months in patients treated with abatacept as a first-line biologic.
Naïve B cells (CD19+CD27-), memory B cells (CD19+CD27+) and plasmablasts (PB CD27++) levels in patients with systemic sclerosis. Indicated points resemble.

Naïve B cells (CD19+CD27-), memory B cells (CD19+CD27+) and plasmablasts (PB CD27++) levels in patients with systemic sclerosis. Indicated points resemble.
Mature and immature NGF forms in patients with JIA and RA

Mature and immature NGF forms in patients with JIA and RA
Conversion to ACPA and RF seronegative status in patients with early RA treated with abatacept+MTX compared with MTX alone. Conversion to ACPA and RF seronegative.

Conversion to ACPA and RF seronegative status in patients with early RA treated with abatacept+MTX compared with MTX alone. Conversion to ACPA and RF seronegative.
MFS1 expression in parental and progeny strains.

MFS1 expression in parental and progeny strains.
Changes in evaluation indicators from baseline to 12 weeks per visit.

Changes in evaluation indicators from baseline to 12 weeks per visit.
Kaplan-Meier survival plots for survival without: (A) progression to RA according to the number of joints with significant synovitis defined by GS≥ grade.

Kaplan-Meier survival plots for survival without: (A) progression to RA according to the number of joints with significant synovitis defined by GS≥ grade.
Percentage of patients achieving EULAR response

Percentage of patients achieving EULAR response
p75NTR, TrkA and sortilin expression levels in patients with JIA

p75NTR, TrkA and sortilin expression levels in patients with JIA
Endochondral bone formation in HLA-B27 transduced ATDC5 micromasses.

Endochondral bone formation in HLA-B27 transduced ATDC5 micromasses.
Association of disease parameters at the time of methotrexate reinitiation during the OLE based on propensity score matching. Association of disease parameters.

Association of disease parameters at the time of methotrexate reinitiation during the OLE based on propensity score matching. Association of disease parameters.
Cells and mediators of the immune-inflammatory ‘cascade’ leading to overt clinical rheumatoid arthritis are described. Cells and mediators of the immune-inflammatory.

Cells and mediators of the immune-inflammatory ‘cascade’ leading to overt clinical rheumatoid arthritis are described. Cells and mediators of the immune-inflammatory.
The patient profiles presented to rheumatologists in the discrete choice experiment (DCE). aCCP, anti-cyclic citrullinated peptide; DAS28, 28-joint Disease.

The patient profiles presented to rheumatologists in the discrete choice experiment (DCE). aCCP, anti-cyclic citrullinated peptide; DAS28, 28-joint Disease.
Frequency of patients in flare at each time point over 3 months

Frequency of patients in flare at each time point over 3 months
The landscape of cytokine-producing CD4 T cell populations in the peripheral blood (PB) and in the joints. Venn diagrams show the frequency of overlapping.

The landscape of cytokine-producing CD4 T cell populations in the peripheral blood (PB) and in the joints. Venn diagrams show the frequency of overlapping.
Conventional treatment to prevent obstetric complications during pregnancy. *Antiphospholipid (aPL) antibody carriers: individuals with aPL positivity.

Conventional treatment to prevent obstetric complications during pregnancy. *Antiphospholipid (aPL) antibody carriers: individuals with aPL positivity.

Similar presentations

Ads by Google